Lilly Wins Victory In Mississippi Zyprexa Case; Judge Says "Aggregate Proof" Of Liability Is Insufficient For Determining Fines
Executive Summary
A federal judge has tossed out most of Mississippi's lawsuit against Lilly over Zyprexa marketing and rebuked the state for seeking excessive penalties
You may also be interested in...
Zyprexa Settlement With W. Virginia Shows States Can Benefit In Solo Suits
Lilly's $22.5 million settlement with West Virginia to resolve litigation over its Zyprexa marketing shows the benefit for states in pursuing suits against pharmaceutical manufacturers on their own
Lilly Will Not Settle Zyprexa Overpricing Suit; Judge Finds Evidence Of Fraud
Lilly intends to fight rather than settle a suit by third party payers alleging the company overpriced its antipsychotic drugZyprexa (olanzapine)
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011